Analytical and Bioanalytical Chemistry 2011-02-01

Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine.

Sabina Strano-Rossi, Ana Maria Bermejo, Xavier de la Torre, Francesco Botrè

Index: Anal. Bioanal. Chem 399(4) , 1623-30, (2011)

Full Text: HTML

Abstract

A fast gas chromatography (GC)-MS method has been developed and validated for the simultaneous screening of different classes of drugs of abuse in urine. Tetrahydrocannabinol metabolite, cocaine, opiates such as morphine, O-6-monoacetylmorphine (O-6-MAM), codeine, opioids such as buprenorphine, methadone, pentazocine, fentanyl and analogues and their main metabolites can be detected and quantified after a simple liquid-liquid extraction in alkaline conditions and derivatisation to obtain the corresponding trimethylsilyl derivatives. The chromatographic separation is performed in a total time of 6 min, using a short GC column (5% phenyl methyl silicone, 10-m length × 0.18-mm internal diameter). The Limits of Detection are satisfactory for forensic purposes for all the substances; the repeatability of concentrations (percent coefficients of variation) are always lower than 15% at high and low concentration levels, and accuracy, intended as % error on the true value, is always lower than 15% for all the analytes. The method can successfully be applied for screening analyses in many fields of forensic toxicology.


Related Compounds

  • Δ9-tetrahydrocanna...

Related Articles:

[Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry].

2010-11-01

[Se Pu 28(11) , 1015-9, (2010)]

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.

2009-11-01

[Drug Alcohol Depend. 105(1-2) , 24-32, (2009)]

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

2009-10-01

[J. Anal. Toxicol. 33(8) , 469-77, (2009)]

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.

2012-06-01

[Addiction 107(6) , 1123-31, (2012)]

[Interpretation of blood analysis data found after passive exposure to cannabis].

2010-01-01

[Arch. Kriminol. 225(3-4) , 90-8, (2010)]

More Articles...